SCHEMBL5316401

SCHEMBL5316401

CON[C@H]1CC2(CCC2)Oc2c1cc(O)c(C)c2C

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.33
PDPK1 O15530 1/20 0.33
PHLPP1 O60346 1/20 0.33
ILK Q13418 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5315842 1.00 AKT1 (0.33) AKT1PDPK1PHLPP1ILK
SCHEMBL4476260 1.00 AKT1 (0.33) AKT1PDPK1PHLPP1ILK
SCHEMBL5317161 0.87
SCHEMBL5312107 0.87
SCHEMBL4469852 0.87 AKT1 (0.34) AKT1PDPK1PHLPP1ILK
SCHEMBL5266292 0.83 AKT1 (0.33) AKT1PDPK1PHLPP1ILK
SCHEMBL5320882 0.82 CTSD (0.30)
SCHEMBL4463143 0.79 AKT1 (0.34) AKT1PDPK1PHLPP1ILK
SCHEMBL4466962 0.78 PTGS1 (0.30)
SCHEMBL5314320 0.75 AKT1 (0.33) AKT1PDPK1PHLPP1ILK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836183-A2 SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS Galileo Pharmaceuticals, Inc. (US) 2007-09-26 EP disclosed
WO-2006065686-A2 SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS GALILEO PHARMACEUTICALS, INC. (US) 2006-06-22 WO disclosed